Tonghua Dongbao Pharmaceutical Co Ltd600867
▲ PositiveCapitalrelevance
Net profit attributable to parent rises 37.32% year on year in H1 2026.

Tonghua Dongbao released its 2026 semi-annual report, during which it achieved operating revenue of 1.553 billion yuan, up 11.13% year on year; net profit attributable to shareholders of the listed company was 296 million yuan, up 37.32% year on year.
Tonghua Dongbao Pharmaceutical Co LtdNet profit attributable to parent rises 37.32% year on year in H1 2026.